Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
44.23
-1.06 (-2.34%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Axogen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 251.17 | 225.21 | 187.34 | 159.01 | 138.58 | 127.36 | |
Revenue Growth | 23.57% | 20.21% | 17.81% | 14.74% | 8.82% | 13.41% |
Cost of Revenue | 63.91 | 57.86 | 45.36 | 37.14 | 29.78 | 22.93 |
Gross Profit | 187.27 | 167.35 | 141.98 | 121.87 | 108.81 | 104.43 |
Selling, General & Admin | 164.07 | 142.32 | 117.5 | 115.99 | 112.89 | 105.67 |
Research & Development | 36.05 | 32.89 | 27.77 | 27.34 | 25.63 | 24.18 |
Operating Expenses | 200.11 | 175.2 | 145.26 | 143.33 | 138.52 | 129.84 |
Operating Income | -12.85 | -7.85 | -3.29 | -21.46 | -29.71 | -25.42 |
Interest Expense | -4.17 | -7.7 | -8.21 | -2.84 | -0.62 | -1.36 |
Interest & Investment Income | 2.23 | 1.17 | 1.14 | 1.49 | 0.57 | 0.09 |
Other Non Operating Income (Expenses) | -1.91 | -1.32 | 0.39 | 1.09 | 0.81 | -0.31 |
EBT Excluding Unusual Items | -16.7 | -15.7 | -9.96 | -21.72 | -28.95 | -26.99 |
Other Unusual Items | -16.85 | - | - | - | - | - |
Pretax Income | -33.55 | -15.7 | -9.96 | -21.72 | -28.95 | -26.99 |
Net Income | -33.55 | -15.7 | -9.96 | -21.72 | -28.95 | -26.99 |
Net Income to Common | -33.55 | -15.7 | -9.96 | -21.72 | -28.95 | -26.99 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 50 | 46 | 44 | 43 | 42 | 41 |
Shares Outstanding (Diluted) | 50 | 46 | 44 | 43 | 42 | 41 |
Shares Change | 9.28% | 4.05% | 3.22% | 1.89% | 2.11% | 3.12% |
EPS (Basic) | -0.68 | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 |
EPS (Diluted) | -0.68 | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8.6 | -2.93 | 1.43 | -19.59 | -36.14 | -41.22 |
Free Cash Flow Per Share | 0.17 | -0.06 | 0.03 | -0.46 | -0.86 | -1.00 |
Gross Margin | 74.56% | 74.31% | 75.79% | 76.64% | 78.52% | 81.99% |
Operating Margin | -5.12% | -3.48% | -1.75% | -13.50% | -21.44% | -19.96% |
Profit Margin | -13.36% | -6.97% | -5.32% | -13.66% | -20.89% | -21.19% |
Free Cash Flow Margin | 3.42% | -1.30% | 0.77% | -12.32% | -26.08% | -32.36% |
EBITDA | -5.97 | -0.87 | 3.45 | -16.97 | -26.62 | -22.47 |
EBITDA Margin | -2.38% | -0.39% | 1.84% | -10.67% | -19.20% | -17.64% |
D&A For EBITDA | 6.88 | 6.98 | 6.73 | 4.49 | 3.09 | 2.95 |
EBIT | -12.85 | -7.85 | -3.29 | -21.46 | -29.71 | -25.42 |
EBIT Margin | -5.12% | -3.48% | -1.75% | -13.50% | -21.44% | -19.96% |